• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of eyedrops in glaucoma: how can we help to reduce non-compliance?

作者信息

Chawla Anand, McGalliard Jim N, Batterbury Mark

出版信息

Acta Ophthalmol Scand. 2007 Jun;85(4):464. doi: 10.1111/j.1600-0420.2007.00882.x. Epub 2007 Feb 6.

DOI:10.1111/j.1600-0420.2007.00882.x
PMID:17286557
Abstract
摘要

相似文献

1
Use of eyedrops in glaucoma: how can we help to reduce non-compliance?
Acta Ophthalmol Scand. 2007 Jun;85(4):464. doi: 10.1111/j.1600-0420.2007.00882.x. Epub 2007 Feb 6.
2
[Compliance in glaucoma].[青光眼的依从性]
Oftalmologia. 2008;52(3):7-9.
3
Noncompliance with medical treatment among glaucoma patients in Oman--a cross-sectional descriptive study.阿曼青光眼患者的治疗依从性——一项横断面描述性研究。
Ophthalmic Epidemiol. 2005 Oct;12(5):303-9. doi: 10.1080/09286580500224602.
4
Should patients choose their own eyedrops?患者应该自行选择眼药水吗？
Acta Ophthalmol Scand. 2006 Feb;84(1):150-1. doi: 10.1111/j.1600-0420.2005.00502.x.
5
Persistency with glaucoma medication.青光眼药物治疗的依从性。
Am J Ophthalmol. 2004 Dec;138(6):1093-4; author reply 1094. doi: 10.1016/j.ajo.2004.05.002.
6
Compliance and viewpoint of glaucoma patients in Greece.希腊青光眼患者的依从性和观点。
Eye (Lond). 2000 Oct;14 Pt 5:752-6. doi: 10.1038/eye.2000.197.
7
Chart documentation by general physicians of the glaucoma medications taken by their patients.普通内科医生对其患者所服用青光眼药物的病历记录。
Am J Ophthalmol. 2005 Aug;140(2):344-5. doi: 10.1016/j.ajo.2005.02.041.
8
[Lowering of intraocular pressure with clonidin].
Klin Monbl Augenheilkd. 1972 Feb;160(2):188-93.
9
[Glaucoma--strategy of treatment].
Oftalmologia. 2008;52(3):3-6.
10
Introduction: new insights on enhancing adherence to topical glaucoma medications.引言：提高局部青光眼药物依从性的新见解
Ophthalmology. 2009 Nov;116(11 Suppl):S29. doi: 10.1016/j.ophtha.2009.06.026.

引用本文的文献

1
Clinical Benefits of Preservative-Free Treatment for Glaucoma with a Focus on Preservative-Free Latanoprost.无防腐剂治疗青光眼的临床益处，重点关注无防腐剂的拉坦前列素。
Ophthalmol Ther. 2025 Sep 19. doi: 10.1007/s40123-025-01241-9.
2
Should we reconsider first-line treatments for glaucoma in the setting of meibomian gland dysfunction and ocular surface disease: Glaucoma treatments and its effects.在睑板腺功能障碍和眼表疾病背景下，我们是否应重新考虑青光眼的一线治疗：青光眼治疗及其效果。
Front Ophthalmol (Lausanne). 2023 Feb 6;3:958955. doi: 10.3389/fopht.2023.958955. eCollection 2023.
3
Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats.
工程化肽药物偶联物通过局部给药在大鼠中提供持续的视网膜神经节细胞保护。
J Control Release. 2023 Oct;362:371-380. doi: 10.1016/j.jconrel.2023.08.058. Epub 2023 Sep 4.
4
Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy.非穿透性深层巩膜切除术治疗青光眼后停药对眼表的影响。
Indian J Ophthalmol. 2022 May;70(5):1626-1633. doi: 10.4103/ijo.IJO_2654_21.
5
Ocular Surface Disease Signs and Symptoms in Patients with Pseudoexfoliative Glaucoma: A Case-Control Study.假性剥脱性青光眼患者的眼表疾病体征和症状：一项病例对照研究。
Vision (Basel). 2022 Feb 8;6(1):11. doi: 10.3390/vision6010011.
6
Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops.突尼斯使用防腐剂型抗青光眼滴眼液患者眼表疾病的危险因素
J Curr Ophthalmol. 2021 Jul 5;33(2):128-135. doi: 10.4103/JOCO.JOCO_226_20. eCollection 2021 Apr-Jun.
7
A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.一种低渗凝胶形成型滴眼液可增强具有黑色素结合特性的激酶抑制剂的眼内递送，从而持续保护视网膜神经节细胞。
Drug Deliv Transl Res. 2022 Apr;12(4):826-837. doi: 10.1007/s13346-021-00987-6. Epub 2021 Apr 26.
8
Hydrus microstent implantation for surgical management of glaucoma: a review of design, efficacy and safety.水合微支架植入术用于青光眼的手术治疗：设计、疗效及安全性综述
Eye Vis (Lond). 2019 Oct 22;6:32. doi: 10.1186/s40662-019-0157-y. eCollection 2019.
9
Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma.正常眼压性青光眼患者睑板腺功能障碍与局部前列腺素类似物依从性之间的关联
PLoS One. 2018 Jan 31;13(1):e0191398. doi: 10.1371/journal.pone.0191398. eCollection 2018.
10
Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent.眼内植入聚己内酯青光眼装置长期降低眼内压并释放新型抗青光眼药物
J Control Release. 2018 Jan 10;269:45-51. doi: 10.1016/j.jconrel.2017.11.008. Epub 2017 Nov 7.